- Home
- RMAX vs TMCI Comparison
RMAX vs TMCI Comparison
Compare RMAX & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RMAX | TMCI |
|---|---|---|
| Founded | 1973 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 121.3M | 120.4M |
| IPO Year | 2013 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RMAX | TMCI |
|---|---|---|
| Price | $6.16 | $1.28 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 6 |
| Target Price | ★ $9.00 | $4.77 |
| AVG Volume (30 Days) | 217.6K | ★ 859.7K |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.60 | N/A |
| Revenue | $195,929,000.00 | ★ $212,690,000.00 |
| Revenue This Year | $2.62 | N/A |
| Revenue Next Year | $1.24 | $7.65 |
| P/E Ratio | $10.08 | ★ N/A |
| Revenue Growth | ★ 11.13 | 1.59 |
| 52 Week Low | $5.66 | $1.19 |
| 52 Week High | $10.32 | $8.56 |
Technical Indicators
Market Signals| Indicator | RMAX | TMCI |
|---|---|---|
| Relative Strength Index (RSI) | 45.09 | 33.72 |
| Support Level | $5.66 | N/A |
| Resistance Level | $8.47 | $3.01 |
| Average True Range (ATR) | 0.27 | 0.10 |
| MACD | 0.08 | 0.01 |
| Stochastic Oscillator | 71.09 | 18.56 |
Price Performance
Historical ComparisonAbout RMAX RE/MAX Holdings Inc.
RE/MAX Holdings Inc operates as a franchisor of real estate brokerage services. It recruits and retains agents and sells franchises. The company's operating segments include Real Estate, Mortgage, Marketing Funds, and Others. It generates maximum revenue from the Real Estate segment.
About TMCI Treace Medical Concepts Inc.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.